Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> DOLLAR TREE Latest News

MAY 29, 2014 - TheStreet

A Must Read - Share

Analysts' Actions: Biogen Idec, Home Away, Palo Alto, Twitter

NEW YORK (TheStreet) -- RATINGS CHANGES HomeAway was downgraded at J.P. Morgan to neutral from overweight. Twelve-month price target is $38. Company will likely increase its marketing spend, J.P. Morgan said Biogen Idec was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $375. Company has multiple, midstage pipeline opportunities, J.P. Morgan said. Celgene was downgraded at J.P. Morgan to neutral from overweight. Valuation call, based on a 12-month price target of $170, J.P. Morgan said. [Read: Look at May Auto Sales - No Wonder the Stock Market Is ... Read More

Tags: Analysts' Actions: Biogen Idec, Home Away, Palo Alto, Twitter,  Dollar Tree Latest News